Thursday - February 12, 2026

Category Archives: Science

Cannabinoid Agonist Clinical Trial Pipeline Expands as 20+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s, “Cannabinoid Agonist Pipeline Insight 2025” report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Cannabinoid Agonist pipeline landscape. It covers the Cannabinoid Agonist pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Renal Cancer Clinical Trial Pipeline Accelerates as 75+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Renal Cancer Pipeline Insight 2025” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Renal Cancer pipeline landscape. It covers the Renal Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Epilepsy Treatment Pipeline Shows Strong Momentum as 75+ Pharma Companies in the Race | DelveInsight

DelveInsight’s “Epilepsy Pipeline Insight 2025” report provides comprehensive insights about 75+ companies and 90+ pipeline drugs in the Epilepsy pipeline landscape. It covers the Epilepsy pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Epilepsy pipeline … Continue reading →

Brutons Tyrosine Kinase Inhibitors Treatment Pipeline Shows Strong Momentum as 30+ Pharma Companies in the Race | DelveInsight

DelveInsight’s “Brutons Tyrosine Kinase Inhibitors Pipeline Insight 2025” report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in the Brutons Tyrosine Kinase Inhibitors pipeline landscape. It covers the Brutons Tyrosine Kinase Inhibitors pipeline drug profiles, including clinical and … Continue reading →

Facioscapulohumeral Muscular Dystrophy Market Size in the 7MM is projected to grow at a significant CAGR by 2034, estimates DelveInsight

DelveInsight’s “Facioscapulohumeral Muscular Dystrophy Market Insights, Epidemiology and Market Forecast – 2034” report delivers an in-depth understanding of facioscapulohumeral muscular dystrophy, historical and forecasted epidemiology as well as the facioscapulohumeral muscular dystrophy market trends in the United States, EU4 (Germany, … Continue reading →

Gastroesophageal Reflux Disease Treatment Pipeline Shows Strong Momentum as 10+ Pharma Companies in the Race | DelveInsight

DelveInsight’s, “Gastroesophageal Reflux Disease Pipeline Insight, 2025” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Gastroesophageal Reflux Disease (GERD) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Acute Coronary Syndrome Treatment Pipeline Shows Strong Momentum as 5+ Pharma Companies in the Race | DelveInsight

DelveInsight’s “Acute Coronary Syndrome Pipeline Insight 2025” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in the Acute Coronary Syndrome pipeline landscape. It covers the Acute Coronary Syndrome pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →